Literature DB >> 7007217

Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence.

A J Williams, M J Hastings, C S Easmon, P J Cole.   

Abstract

The importance of several factors involved in the investigation of opsonic defects was studied using phagocytic Luminol-dependent chemiluminescence. The range for the opsonization of zymosan and bakers' yeast by serum from healthy individuals was wide and kinetic studies showed comparative differences for different periods of incubation, serum concentrations and particles. Decay in the opsonic activity of serum stored at different temperatures was demonstrated and its clinical implications emphasized. By using techniques to ablate independently the classical and alternative pathways of complement activation, the contribution of these to the opsonization of zymosan, Staphylococcus aureus (NCTC 6571), Pseudomonas aeruginosa and group B streptococcus (NCTC 11080) by normal and hypogammaglobulinaemic serum at a concentration of 7% was assessed. By comparison of the results obtained for different periods of incubation between particle and serum, the need for consideration of this parameter when assessing opsonic activity was shown. The results using the chemiluminescence assay were compared with those using other methods and were found to correlate well.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7007217      PMCID: PMC1458310     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  11 in total

1.  Classical and alternative complement pathway activation by pneumococci.

Authors:  C G Stephens; R C Williams; W P Reed
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

2.  Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.

Authors:  G S Giebink; J Verhoef; P K Peterson; P G Quie
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

3.  Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.

Authors:  J Verhoef; P Peterson; Y Kim; L D Sabath; P G Quie
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

4.  Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3).

Authors:  C A Alper; N Abramson; R B Johnston; J H Jandl; F S Rosen
Journal:  N Engl J Med       Date:  1970-02-12       Impact factor: 91.245

5.  Plasma therapy in immunodeficiency diseases.

Authors:  R H Buckley
Journal:  Am J Dis Child       Date:  1972-09

6.  A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5).

Authors:  M E Miller; U R Nilsson
Journal:  N Engl J Med       Date:  1970-02-12       Impact factor: 91.245

7.  Kinetics of staphylococcal opsonization, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using [3H]thymidine labeled bacteria.

Authors:  J Verhoef; P K Peterson; P G Quie
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

8.  Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation.

Authors:  A Martin; P J Lachmann; L Halbwachs; M J Hobart
Journal:  Immunochemistry       Date:  1976-04

9.  Complement-mediated phagocytosis of Pseudomonas aeruginosa.

Authors:  P K Peterson; Y Kim; D Schmeling; M Lindemann; J Verhoef; P G Quie
Journal:  J Lab Clin Med       Date:  1978-12

10.  Defective opsonization. A common immunity deficiency.

Authors:  J F Soothill; B A Harvey
Journal:  Arch Dis Child       Date:  1976-02       Impact factor: 3.791

View more
  15 in total

1.  Chemiluminescence response of human polymorphonuclear and mononuclear phagocytic cells induced by Staphylococcus saprophyticus, lectinophagocytosis versus opsonophagocytosis.

Authors:  J Beuth; H L Ko; P Quie; G Pulverer
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

2.  Defective opsonization of Haemophilus influenzae by sera of elderly patients.

Authors:  N D Garbett; G S Matharu; P J Cole
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

3.  Assessment of biological activity of immunoglobulin preparations by using opsonized micro-organisms to stimulate neutrophil chemiluminescence.

Authors:  C S Munro; P J Stanley; P J Cole
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

4.  Surface receptors for IgG and complement on equine alveolar macrophages.

Authors:  R M Dyer; R W Leid
Journal:  Inflammation       Date:  1983-06       Impact factor: 4.092

5.  Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.

Authors:  I Eichler; L Joris; Y P Hsu; J Van Wye; R Bram; R Moss
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

6.  Effects of cefodizime and cefotaxime on cellular and humoral immune responses.

Authors:  G Pulverer
Journal:  Infection       Date:  1992       Impact factor: 3.553

7.  Immune thrombocytopenia and Fc receptor-mediated phagocyte function.

Authors:  A C Newland; M G Macey
Journal:  Ann Hematol       Date:  1994-08       Impact factor: 3.673

8.  Differences in virulence within the species Bacteroides gingivalis.

Authors:  T J Van Steenbergen; F G Delemarre; F Namavar; J De Graaff
Journal:  Antonie Van Leeuwenhoek       Date:  1987       Impact factor: 2.271

9.  The onset of polymorphonuclear leucocyte membrane-stimulated metabolic activity.

Authors:  A J Williams; P J Cole
Journal:  Immunology       Date:  1981-08       Impact factor: 7.397

10.  Investigation of alveolar macrophage function using lucigenin-dependent chemiluminescence.

Authors:  A J Williams; P J Cole
Journal:  Thorax       Date:  1981-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.